Bicocca Open Archive

Logo unimib boa
OKOLICSANYI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.258
EU - Europa 2.592
AS - Asia 2.559
SA - Sud America 457
Continente sconosciuto - Info sul continente non disponibili 383
AF - Africa 78
OC - Oceania 10
Totale 12.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.894
SG - Singapore 910
CN - Cina 641
IT - Italia 590
DE - Germania 390
RU - Federazione Russa 352
BR - Brasile 335
CA - Canada 324
VN - Vietnam 307
SE - Svezia 298
HK - Hong Kong 261
IE - Irlanda 211
UA - Ucraina 175
GB - Regno Unito 165
IN - India 129
FR - Francia 87
DK - Danimarca 68
AT - Austria 67
BD - Bangladesh 58
FI - Finlandia 53
AR - Argentina 44
TR - Turchia 43
IQ - Iraq 31
ES - Italia 30
NL - Olanda 26
MX - Messico 24
ZA - Sudafrica 23
SA - Arabia Saudita 22
BE - Belgio 21
KR - Corea 21
JP - Giappone 19
EC - Ecuador 18
CO - Colombia 17
PK - Pakistan 15
PL - Polonia 15
PH - Filippine 14
VE - Venezuela 12
ID - Indonesia 11
MA - Marocco 11
MY - Malesia 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 7
NP - Nepal 7
PE - Perù 7
PY - Paraguay 7
TN - Tunisia 7
AU - Australia 6
ET - Etiopia 6
IR - Iran 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
TW - Taiwan 6
AZ - Azerbaigian 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
BO - Bolivia 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
EU - Europa 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
TH - Thailandia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
LY - Libia 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
ZM - Zambia 2
A1 - Anonimo 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
Totale 11.944
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Ashburn 528
Singapore 517
Woodbridge 462
Fairfield 339
San Jose 319
Houston 300
Chandler 271
Hong Kong 258
Toronto 236
Wilmington 231
Frankfurt am Main 215
Dublin 203
Milan 173
Dearborn 166
Jacksonville 157
New York 155
Seattle 137
Cambridge 133
Council Bluffs 101
Beijing 93
Santa Clara 93
Dallas 92
Los Angeles 91
Princeton 81
Ho Chi Minh City 79
Hanoi 74
The Dalles 67
Vienna 65
Nanjing 64
Chicago 61
Rome 55
Shanghai 54
Altamura 39
Buffalo 39
Lawrence 38
Lauterbourg 34
Columbus 32
Moscow 32
Orem 28
Lachine 26
São Paulo 26
Guangzhou 24
Nanchang 23
Shenyang 23
Tianjin 23
Boardman 22
Helsinki 20
San Diego 20
Washington 19
Dong Ket 18
Phoenix 18
Boston 17
Da Nang 16
Fremont 16
Munich 16
Ottawa 16
Brooklyn 15
Brussels 15
Hefei 15
Tokyo 15
Jinan 14
Johannesburg 14
Rio de Janeiro 14
Haiphong 13
Manchester 13
Andover 12
Baghdad 12
Dhaka 12
Kunming 12
Lissone 12
London 12
Warsaw 12
Changsha 11
Edmonton 11
Seoul 11
Mountain View 10
Nürnberg 10
Atlanta 9
Brasília 9
Denver 9
Kuala Lumpur 9
Mexico City 9
Montreal 9
New Delhi 9
Salt Lake City 9
Zhengzhou 9
Chennai 8
Falls Church 8
Hangzhou 8
Hebei 8
Hải Dương 8
Jeddah 8
Jiaxing 8
Mumbai 8
Sacramento 8
San Francisco 8
Valencia 8
Amsterdam 7
Buenos Aires 7
Totale 7.765
Salva come PNG Salva come JPEG
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 533
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 500
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 467
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 403
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 395
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 370
Health related quality of life in chronic liver diseases 346
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 333
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 330
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 328
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 323
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 315
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 312
The impact of liver disease on the health-related quality of life 312
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 309
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 308
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 297
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 296
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 296
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 295
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 294
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 294
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 289
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 287
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 282
Difference in health related quality of life of chronic liver diseases and general population 280
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 279
Health Related Quality of Life in the Major Liver Conditions 276
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 273
Liver-allocation policies for patients affected by HCC in Europe 270
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 266
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 265
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 259
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 253
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 249
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 248
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 246
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 238
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 228
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 193
Totale 12.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022500 0 59 72 57 16 41 19 41 26 37 38 94
2022/20231.054 106 369 88 90 56 139 21 73 68 3 31 10
2023/2024647 21 27 15 49 58 213 127 24 40 6 5 62
2024/20251.504 86 160 115 47 123 59 99 49 196 260 109 201
2025/20263.909 472 158 303 325 422 187 514 150 315 393 383 287
2026/2027231 83 148 0 0 0 0 0 0 0 0 0 0
Totale 12.337